Today, the Department of Health and Human Services released further detail on its most favored nation (MFN) pricing proposal for pharmaceuticals sold in the US. According to the press release issued by the department the target price will be lowest price in a country (that is, a member of the Organization for Economic Cooperation and … Continue reading The Trump Most Favored Nation Pricing Proposal: Bad News for Biosimilars